SCOPUS 정보 검색 플랫폼

Journal of Theoretical Medicine

Volumn 3, Issue 1, 2000, Pages 11-23

Modelling the effects of Paclitaxel and Cisplatin on breast and ovarian cancer

(3) Panetta, Joh Carl a Chaplain, Mark A J b Cameron, David c

a ST JUDE CHILDREN S RESEARCH HOSPITAL (United States)

b UNIVERSITY OF DUNDEE (United Kingdom)

c UNIVERSITY OF EDINBURGH (United Kingdom)

Author keywords

Cancer; Cisplatin; Combination chemotherapy; Ordinary differential equations; Paclitaxel

Indexed keywords

CISPLATIN; PACLITAXEL;

ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CELL CYCLE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; MATHEMATICAL MODEL; OVARY CANCER; PHARMACODYNAMICS; PHARMACOKINETICS; PREDICTION;

EID: 0034582619 PISSN: 10273662 EISSN: None Source Type: Journal
DOI: 10.1080/10273660008833061 Document Type: Article

Times cited : (5)

References (20)

1
- 0028296117
- Paclitaxel (taxol) in breast cancer
- (1994) Breast Cancer , vol.8 , Issue.1 , pp. 121-140
- Arbuck, S.G.¹ Dorr, A.² Friedman, M.A.³

2
- 0024847290
- What is synergy?
- (1989) Pharmacol. Rev , vol.41 , pp. 93-142
- Berenbaum, M.C.¹

3
- 8044233696
- p53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: A molecular and immunohistochemical study
- (1997) Br. J. Cancer , vol.75 , pp. 230-235
- Buttitta, F.¹ Marchetti, A.² Gadducci, A.³ Pellegrini, S.⁴ Morganti, M.⁵ Carnicelli, V.⁶ Cosio, S.⁷ Gagetti, O.⁸ Genazzani, A.R.⁹ Bevilacqua, G.¹⁰

4
- 0021118703
- Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors
- (1986) Adv. Enzyme Reg , vol.22 , pp. 27-55
- Chou, T.C.¹ Talalay, P.²

5
- 9844220294
- Differential modulation of cisplatin accumulation in leukocytes and tumor cell lines by the paclitaxel vehicle Cremophor EL
- (1997) Annals of Oncology , vol.8 , pp. 1145-1150
- de Vos, A.I.¹ Nooter, K.² Verwejj, J.³ Loos, W.J.⁴ Brouwer, E.⁵ deBruijn, P.⁶ Ruijgrok, E.J.⁷ van der Burg, M.E.L.⁸ Stoter, G.⁹ Sparreboom, A.¹⁰

6
- 0031036695
- p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel
- (1997) Cancer Res , vol.57 , pp. 870-874
- Debernardis, D.¹ Sire, E.G.² De Feudis, P.³ Vikhanskaya, F.⁴ Valenti, M.⁵ Russo, P.⁶ Parodi, S.⁷ D'Incalci, M.⁸ Broggini, M.⁹

7
- 0029776807
- Paclitaxel and cisplatin sensitivity of ovarian carcinoma cell lines tested with the 96-well plate clonogenic assay
- (1996) Anticancer Research , vol.16 , Issue.4 A , pp. 1743-1747
- Engblom, P.¹ Rantanen, V.² Kulmala, J.³ Grenman, S.⁴

8
- 0029036955
- The search for synergy: A critical review from a response surface perspective
- (1995) Pharmacological Reviews , vol.47 , Issue.2 , pp. 331-385
- Greco, R.W.¹ Bravo, G.² Parsons, J.C.³

9
- 0028158664
- Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells. in vitro
- (1994) British Journal of Cancer , vol.69 , Issue.2 , pp. 299-306
- Jekunen, A.P.¹ Christen, R.D.² Shalinsky, D.R.³ Howell, S.B.⁴

10
- 0031747118
- Cisplatin- and paclitaxel-induced apoptosis of ovarian carcinoma cells and the relationship between bax and bak up-regulation and the functional status of p53
- (1998) Molecular Pharmacology , vol.53 , Issue.5 , pp. 819-826
- Jones, N.A.¹ Turner, A.J.² McIlwrath, J.³ Brown, R.⁴ Dive, C.⁵

11
- 0030860270
- Combined action of paclitaxel and cisplatin against wildtype and resistant human ovarian carcinoma cells
- (1997) Cancer Chemother. Parmacol , vol.40 , pp. 495-505
- Levasseur, L.M.¹ Greco, W.R.² Rustum, Y.M.³ Slocum, H.K.⁴

12
- 0028346310
- Sequence dependence of paclitaxel (taxol) combined with cisplatin or alkylators in human cancer cells
- (1994) Oncology Research , vol.6 , Issue.1 , pp. 25-31
- Liebmann, J.¹ Fisher, J.E.² Teague, D.³ Cook, J.A.⁴

13
- 0009081551
- Taxol induces apoptosis by a p53/p21 independent mechanism in cisplatin resistant ovarian carcinoma cells (meeting abstract)
- (1997) Proc. Annu. Meet. Am. Assoc. Cancer Res , vol.38
- Menendez, A.T.¹ Laidlaw, J.² Raventos-Suarez, C.³ Gelbert, L.⁴ Granas, A.⁵ Li, M.⁶ Kramer, R.⁷

14
- 0029090720
- Sequence-dependent antitumor activity of paclitaxel (taxol) and cisplatin in vivo
- (1995) International Journal of Cancer , vol.62 , Issue.5 , pp. 599-604
- Milross, C.G.¹ Peters, L.J.² Hunter, N.R.³ Mason, K.A.⁴ Milas, L.⁵

15
- 0030867447
- A mathematical model of breast and ovarian cancer treated with paclitaxel
- (1997) Math. Biosci , vol.146 , Issue.2 , pp. 89-113
- Panetta, J.C.¹

16
- 0027862598
- Taxol effect on cisplatin sensitivity and cisplatin cellular accumulation in human ovarian cancer cells
- (1993) Journal of the National Cancer Institute , vol.15 , pp. 83-88
- Parker, R.J.¹ Dabholkar, M.D.² Lee, K.B.³ Bostick-Bruton, F.⁴ Reed, E.⁵

17
- 0025850566
- Sequences of taxol and cisplatin: A phase i and pharmacologic study
- (1991) J. Clin. Oncol , vol.9 , Issue.9 , pp. 1692-1703
- Rowinsky, E.K.¹ Gilbert, M.R.² McGuire, W.P.³ Noe, D.A.⁴ Grochow, L.B.⁵ Forastiere, A.A.⁶ Ettinger, D.S.⁷ Lubejko, B.G.⁸ Clark, B.⁹ Sartorius, S.E.¹⁰ Cornblath, D.R.¹¹ Hendricks, C.B.¹² Donehower, R.C.¹³

18
- 0031867659
- Therapy effect of either paclitaxel or cyclophosphamide combination treatment in patients with epithelial ovarian cancer and relation to tp53 gene status
- (1998) Br. J. Cancer , vol.78 , pp. 375-381
- Smith-Srensen, B.¹ Kaern, J.² Holm, R.³ Drum, A.⁴ Trope, C.⁵ Brresen-Dale, A.L.⁶

19
- 0027968083
- Paclitaxel. a review of its pharmacodynamic and pharmacokinetics properties and therapeutic potential in the treatment of cancer
- (1994) Drugs , vol.48 , Issue.5 , pp. 794-847
- Spencer, C.M.¹ Faulds, D.²

20
- 0028873707
- Schedule-dependent antagonism of paclitaxel and cisplatin in human gastric and ovarian carcinoma cell lines. in vitro
- (1995) European Journal of Cancer , vol.31 A , Issue.1 , pp. 92-97
- Vanhoefer, U.¹ Harstrick, A.² Wilke, H.³ Schleucher, N.⁴ Walles, H.⁵ Schroder, J.⁶ Seeber, S.⁷

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.